Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model
Frontiers in Pharmacology · 18.11.2026 · 17
DOI: 10.3389/fphar.2026.1934298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.11.2026. Verfasst von Meifang Du und 10 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ethnopharmacological relevance Helicobacter pylori ( H. pylori ) is the only confirmed pathogenic bacterium that can persistently colonize the stomach and cause gastric mucosal inflammation and related diseases. Massa Medicata Fermentata (MMF), a classical traditional fermented Chinese medicine, is commonly used clinically—either unprocessed or stir-fried—to treat gastric disorders such as dyspepsia; however, its pharmacological mechanisms against H. pylori infection remain unclear.
Objective
To comparatively analyze the antibacterial effects of naturally fermented MMF and its stir-fried MMF on H. pylori in vivo and in vitro . Materials and method Naturally fermented MMF was stir-fry processed for different durations to produce three types: golden-, aromatic-, and charred-MMF; their biochemical characteristics and components were then evaluated. Co-culture experiments assessed the effects of MMF on H. pylori growth in vitro . Finally, a mouse H. pylori infection model was established; interventions with the four MMF types, alone or combined with anti- H. pylori immunoglobulin Y (IgY- Hp ), were administered for 2 weeks, and both H. pylori burden and gastrointestinal function were measured.
Results
Naturally fermented MMF exerted a direct effect on the growth and infection of H. pylori . Stir-fry processing not only markedly altered MMF appearance and biochemical profiles, but also enhanced its inhibitory activity against H. pylori growth. In H. pylori –infected mice, aromatic- and charred-MMF reduced gastric H. pylori burden, with 37.5% of treated animals (3/8) testing RUT-negative versus 25% for original MMF. Interestingly, combining MMF with IgY- Hp further enhanced the anti- H. pylori activity of MMF; notably, the aromatic-MMF + IgY- Hp group demonstrated a synergistic inhibitory effect on H. pylori growth (FICI = 0.5) and achieved the largest reduction in H. pylori burden in vivo , with 62.5% of treated animals (5/8) testing RUT-negative. This group also showed significantly improved gastrointestinal function, including gastric emptying and small-intestinal propulsion (p < 0.05), as well as serum gastrin, motilin, and somatostatin levels. Further GC-MS analysis revealed that stir-frying markedly altered the chemical components of MMF, such as 5-hydroxymethylfurfural (5-HMF) and 1-Ethyl-2-formylpyrrole, whose changes are consistent with the variation in antibacterial activity of stir-fried MMF.
Conclusion
Stir-fry processing significantly altered the appearance, biochemical profile, and composition of MMF and exerted a significantly stronger anti- H. pylori effect, especially for aromatic-MMF, compared with naturally fermented MMF. In addition, MMF combined with IgY- Hp significantly increased antibacterial activity in vitro and in vivo and promoted recovery of gastrointestinal function, suggesting a potentially effective and non-antibiotic therapeutic option.
Zitieren
APA
Du, M., Guo, R., Xie, R., Luo, X., Wang, B., Yang, T., Chen, N., Jiang, H., Li, Z., Jian, X., & Zhang, Z. (2026). Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1934298
Vancouver
Du M, Guo R, Xie R, Luo X, Wang B, Yang T, et al. Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1934298
BibTeX
@article{Du2026,
author = {Du, Meifang and Guo, Rong and Xie, Ruilin and Luo, Xiaoling and Wang, Bin and Yang, Taibing and Chen, Nanlin and Jiang, Hao and Li, Zaixin and Jian, Xiaohong and Zhang, Zhi},
title = {Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1934298}
}
EUVIMED